comparemela.com

Bien Commun Advisory News Today : Breaking News, Live Updates & Top Stories | Vimarsana

EQS-News: Andera Partners co-leads a €40 million Series A of Dualyx, a Belgian biotech developing novel Treg therapies for autoimmune diseases

EQS-News: Andera Partners / Key word(s): Financing Andera Partners co-leads a €40 million Series A of Dualyx, a Belgian biotech developing novel Treg therapies for autoimmune diseases 15.05.2023

EQS-News: Andera Partners co-leads a Series A extension round totalling € 47 75 million for radiopharmaceutical company Ariceum Therapeutics

EQS-News: Andera Partners / Key word(s): Financing Andera Partners co-leads a Series A extension round totalling € 47.75 million for radiopharmaceutical company Ariceum Therapeutics 18.04.2023 / 09:15 CET/CEST The issuer is solely responsible for the content of this announcement. PRESS RELEASE A.

EQS-News: Andera Partners leads $48 5 Million Series A financing for medical device company BioVentrix®

EQS-News: Andera Partners / Key word(s): Financing Andera Partners leads $48.5 Million Series A financing for medical device company BioVentrix® 13.04.2023 / 12:45 CET/CEST The issuer

EQS-News: Andera Partners co-leads $25m extension round for FIRE1, an Irish medtech developing breakthrough technology for patients with heart failure

EQS-News: Andera Partners co-leads $25m extension round for FIRE1, an Irish medtech developing breakthrough technology for patients with heart failure
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

EQS-News: Ahead of its business plan, Andera Partners approaches 4 billion euros in assets under management and announces a new 2028 target of 6 to 8 billion euros

EQS-News: Andera Partners / Key word(s): Funds Ahead of its business plan, Andera Partners approaches 4 billion euros in assets under management and announces a new 2028 target of 6 to 8 billion euros 16.02.2023 / 09:00 CET/CEST The issuer is solely responsible for the content of this announceme.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.